Hepatitis G virus: clinical relevance and responsiveness to interferon
Cheung, R.C.; Keeffe, E.B.
American Journal of Gastroenterology 92(11): 1957-1959
1997
ISSN/ISBN: 0002-9270 PMID: 9362171 Document Number: 483057
Document emailed within 1 workday
Related Documents
Sarrazin, C.; Roth, W.K.; Zeuzem, S. 1998: GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance Zeitschrift für Gastroenterologie 36(11): 997-1008Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Kao, J-Horng.; Chen, D-Shinn. 2003: Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan Gastroenterology 125(6): 1916-7; author reply 1917-8
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Lee, C.-M.; Hung, C.-H.; Lu, S.-N.; Changchien, C.-S. 2008: Hepatitis C virus genotypes: clinical relevance and therapeutic implications Chang Gung Medical Journal 31(1): 16-25
Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Kaji, K.; Unoura, M.; Kobayashi, K.; Nakanuma, Y. 1994: Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1865-1868
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Ohnishi, K.; Nomura, F.; Nakano, M. 1991: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status American Journal of Gastroenterology 86(8): 1041-1049
Paul, S.; Tabassum, S.; Islam, M.N. 2004: Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection Bangladesh Medical Research Council Bulletin 30(2): 71-77
Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Kaiser, T.; Tillmann, H.L. 2005: GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? Aids Reviews 7(1): 3-12
Desmond, C.P.; Bartholomeusz, A.; Gaudieri, S.; Revill, P.A.; Lewin, S.R. 2008: A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics Antiviral Therapy 13(2): 161-175
Taillan, B.; Ferrari, P.; Fuzibet, J.G.; Ferrari, E.; Quaranta, J.F.; Dujardin, P. 1991: Mixed cryoglobulinemia in hepatitis C virus infection. Value of interferon therapy Presse Medicale 20(29): 1392-1393
Fernández, B.; Basaras, M.; Blanco, S.; Sánchez, S.; Arrese, E.; de las Heras, B.; Cisterna, R. 2003: Hepatitis C virus variability and interferon-mediated pathway inhibition Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 16(3): 325-329